Ensysce Biosciences (ENSC) Competitors $2.10 -0.03 (-1.41%) Closing price 04:00 PM EasternExtended Trading$2.12 +0.02 (+0.95%) As of 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ENSC vs. FBLG, AKTX, NAII, SNYR, PASG, CTXR, ALLR, RLYB, NNVC, and SONNShould you be buying Ensysce Biosciences stock or one of its competitors? The main competitors of Ensysce Biosciences include FibroBiologics (FBLG), Akari Therapeutics (AKTX), Natural Alternatives International (NAII), Synergy CHC (SNYR), Passage Bio (PASG), Citius Pharmaceuticals (CTXR), Allarity Therapeutics (ALLR), Rallybio (RLYB), NanoViricides (NNVC), and Sonnet BioTherapeutics (SONN). These companies are all part of the "pharmaceutical products" industry. Ensysce Biosciences vs. Its Competitors FibroBiologics Akari Therapeutics Natural Alternatives International Synergy CHC Passage Bio Citius Pharmaceuticals Allarity Therapeutics Rallybio NanoViricides Sonnet BioTherapeutics Ensysce Biosciences (NASDAQ:ENSC) and FibroBiologics (NASDAQ:FBLG) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, media sentiment, valuation, earnings and analyst recommendations. Is ENSC or FBLG more profitable? FibroBiologics has a net margin of 0.00% compared to Ensysce Biosciences' net margin of -88.76%. Ensysce Biosciences' return on equity of -167.23% beat FibroBiologics' return on equity.Company Net Margins Return on Equity Return on Assets Ensysce Biosciences-88.76% -167.23% -104.59% FibroBiologics N/A -710.25%-118.02% Do insiders & institutionals believe in ENSC or FBLG? 5.6% of Ensysce Biosciences shares are owned by institutional investors. 7.9% of Ensysce Biosciences shares are owned by company insiders. Comparatively, 20.8% of FibroBiologics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has better earnings & valuation, ENSC or FBLG? Ensysce Biosciences has higher revenue and earnings than FibroBiologics. FibroBiologics is trading at a lower price-to-earnings ratio than Ensysce Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnsysce Biosciences$5.21M1.20-$7.99M-$4.03-0.52FibroBiologicsN/AN/A-$11.16M-$0.36-1.58 Does the media refer more to ENSC or FBLG? In the previous week, Ensysce Biosciences had 1 more articles in the media than FibroBiologics. MarketBeat recorded 2 mentions for Ensysce Biosciences and 1 mentions for FibroBiologics. FibroBiologics' average media sentiment score of 0.00 beat Ensysce Biosciences' score of -0.14 indicating that FibroBiologics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ensysce Biosciences 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral FibroBiologics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend ENSC or FBLG? FibroBiologics has a consensus price target of $13.00, indicating a potential upside of 2,183.11%. Given FibroBiologics' stronger consensus rating and higher possible upside, analysts plainly believe FibroBiologics is more favorable than Ensysce Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ensysce Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00FibroBiologics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk & volatility, ENSC or FBLG? Ensysce Biosciences has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500.Comparatively, FibroBiologics has a beta of -0.73, meaning that its share price is 173% less volatile than the S&P 500. SummaryEnsysce Biosciences and FibroBiologics tied by winning 7 of the 14 factors compared between the two stocks. Get Ensysce Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ENSC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ENSC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ENSC vs. The Competition Export to ExcelMetricEnsysce BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.34M$3.16B$5.77B$9.97BDividend YieldN/A2.27%6.70%4.53%P/E RatioN/A21.4375.8426.48Price / Sales1.20420.96524.96210.41Price / CashN/A44.1225.7029.11Price / Book0.819.7811.916.14Net Income-$7.99M-$53.22M$3.28B$265.92M7 Day Performance0.48%2.52%1.11%7.70%1 Month Performance-3.67%11.45%8.17%11.82%1 Year Performance-62.57%15.49%67.79%31.45% Ensysce Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ENSCEnsysce Biosciences0.1498 of 5 stars$2.10-1.4%N/A-62.0%$6.34M$5.21M0.0010FBLGFibroBiologics2.4873 of 5 stars$0.59-4.9%$13.00+2,103.0%-72.5%$24.72MN/A-1.6410AKTXAkari Therapeutics2.7151 of 5 stars$0.76-5.8%$5.00+557.9%-75.3%$24.45MN/A0.009News CoverageShort Interest ↑NAIINatural Alternatives InternationalN/A$3.88+8.2%N/A-47.3%$23.05M$113.80M-2.79290Positive NewsGap DownSNYRSynergy CHC3.8329 of 5 stars$2.42+14.2%$10.00+313.2%N/A$22.85M$34.83M6.3740High Trading VolumePASGPassage Bio3.2756 of 5 stars$7.13+3.3%$91.75+1,186.8%-49.5%$22.66MN/A-0.39130Analyst UpgradeCTXRCitius Pharmaceuticals2.4731 of 5 stars$1.33-5.0%$53.00+3,885.0%-90.7%$22.63MN/A0.0020Gap DownHigh Trading VolumeALLRAllarity Therapeutics2.4098 of 5 stars$1.54+2.7%$9.00+484.4%-60.3%$22.51MN/A0.0010RLYBRallybio3.1295 of 5 stars$0.54-4.2%$5.00+831.8%-44.7%$22.42M$640K-0.5740Short Interest ↓Gap UpNNVCNanoViricides0.7288 of 5 stars$1.39-1.8%N/A-11.8%$22.34MN/A-1.9320Short Interest ↓SONNSonnet BioTherapeutics1.8562 of 5 stars$3.25-3.8%$20.00+515.4%-59.1%$22.19M$20K0.0010Negative NewsShort Interest ↑Gap Up Related Companies and Tools Related Companies FBLG Alternatives AKTX Alternatives NAII Alternatives SNYR Alternatives PASG Alternatives CTXR Alternatives ALLR Alternatives RLYB Alternatives NNVC Alternatives SONN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ENSC) was last updated on 9/8/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ensysce Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ensysce Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ENSC Stock Alerts